ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Charles M. Lieber, an expert in nanoscience and former chair of Harvard University’s Chemistry and Chemical Biology Department, was indicted by a federal grand jury on June 9. The grand jury formally charged Lieber with two counts of making false statements about his association with China’s Thousand Talents program. He will appear before a Boston federal court to answer the charges at a later date, according to a press release from the US Department of Justice.
Lieber was first arrested for alleged fraud on Jan. 28. He has been out on $1 million bail since Jan. 30. He is currently on leave from Harvard.
US federal authorities allege that unbeknownst to Harvard, Lieber accepted a position at Wuhan University of Technology in 2011 and joined the Thousand Talents program from 2012 to 2015. Lieber and his research group have received more than $15 million in research grants from the US National Institutes of Health (NIH) and Department of Defense (DOD), agencies that require their grantees to disclose all sources of research funding, potential financial conflicts of interest, and foreign collaborations.
The indictment claims that Lieber told investigators from the DOD that he was never asked to participate in the Thousand Talents Program. It also says that Lieber misled Harvard, causing the university to falsely claim to the NIH that he had never participated in the Chinese program.
“The government has this wrong. Professor Lieber has dedicated his life to science and to his students,” Lieber’s attorneys Marc Mukasey and Torrey Young say in a statement. “When justice is done, Charlie’s good name will be restored and the scientific community again will be able to benefit from his intellect and passion.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X